SEC Form 4 · accession 0000899243-18-031746

SOLENO THERAPEUTICS INC · SLNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Dec 21, 2018

Accepted (ET)

Dec 26, 2018 · 9:47 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001484565

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, par value $0.001 per share ("Common Stock")^F1	Dec 21, 2018	P	3,031,002	$1.6063	A	4,550,678	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Warrant (Right to Buy)^F3,F1,F2	$2.00	Dec 21, 2018	P	151,550	A	—	Dec 21, 2023	Common Stock	151,550	1,276,110	I

F1The shares and warrants are held of record by the Jack W. Schuler Living Trust (the "Living Trust"). Jack W. Schuler serves as the sole trustee of the Living Trust, and in such capacity may be deemed to beneficially own the shares and warrants held by the Living Trust.
F2The Living Trust owns warrants for 1,276,110 shares of Common Stock that are not currently exercisable due to restrictions on exercise that prevent the holder from exercising them to the extent it and its affiliates would beneficially own more than 19.99% of the Common Stock (the "19.99% Limitation").
F3The reported securities are included within 3,031,002 units purchased by Partners for $1.60625 per unit. Each unit consists of one share of common stock and one warrant to acquire 5% of a share of Common Stock.